Our monthly newsletter reports on the patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month’s issue covers relevant news from November 2019, including:

• Federal Circuit affirms the Patent Trial and Appeal Board’s (“PTAB”)’s application of the “blocking patent” doctrine as applied to objective indicia of non-obviousness

• District court orders production of privileged documents reviewed by a Rule 30(b)(6) witness in preparation for her deposition

• More patent-busting draft legislation in the US Senate